Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
RNA, Transfer | 72 | 2024 | 151 | 16.620 |
Why?
|
RNA Processing, Post-Transcriptional | 25 | 2022 | 105 | 6.590 |
Why?
|
RNA | 35 | 2022 | 560 | 5.530 |
Why?
|
Protein Biosynthesis | 33 | 2021 | 378 | 5.150 |
Why?
|
RNA, Catalytic | 36 | 2006 | 129 | 5.080 |
Why?
|
Adenosine | 24 | 2021 | 225 | 5.030 |
Why?
|
Nucleic Acid Conformation | 49 | 2018 | 332 | 4.410 |
Why?
|
RNA, Messenger | 27 | 2022 | 1981 | 4.380 |
Why?
|
RNA, Long Noncoding | 11 | 2021 | 102 | 4.180 |
Why?
|
Pseudouridine | 8 | 2022 | 19 | 3.750 |
Why?
|
Bacillus subtilis | 30 | 2018 | 89 | 3.540 |
Why?
|
High-Throughput Nucleotide Sequencing | 9 | 2023 | 456 | 3.430 |
Why?
|
Endoribonucleases | 25 | 2003 | 92 | 3.200 |
Why?
|
RNA, Bacterial | 25 | 2012 | 108 | 2.950 |
Why?
|
Nucleoside Q | 6 | 2022 | 8 | 2.830 |
Why?
|
Transfer RNA Aminoacylation | 10 | 2020 | 18 | 2.730 |
Why?
|
Anticodon | 11 | 2022 | 18 | 2.340 |
Why?
|
Escherichia coli | 16 | 2022 | 597 | 2.290 |
Why?
|
Amino Acids | 11 | 2023 | 252 | 2.280 |
Why?
|
Methionine | 6 | 2017 | 66 | 2.270 |
Why?
|
RNA-Binding Proteins | 11 | 2020 | 246 | 2.150 |
Why?
|
Ribonuclease P | 36 | 2010 | 54 | 2.080 |
Why?
|
HEK293 Cells | 23 | 2021 | 615 | 2.050 |
Why?
|
Escherichia coli Proteins | 9 | 2021 | 179 | 2.030 |
Why?
|
Base Sequence | 52 | 2023 | 2330 | 1.960 |
Why?
|
RNA Precursors | 14 | 2019 | 69 | 1.840 |
Why?
|
Codon | 14 | 2023 | 124 | 1.790 |
Why?
|
Stress, Physiological | 6 | 2018 | 226 | 1.670 |
Why?
|
Transcriptome | 10 | 2021 | 580 | 1.650 |
Why?
|
Transcription, Genetic | 11 | 2019 | 1135 | 1.620 |
Why?
|
HeLa Cells | 21 | 2021 | 498 | 1.550 |
Why?
|
MicroRNAs | 3 | 2022 | 534 | 1.550 |
Why?
|
Molecular Sequence Data | 40 | 2016 | 3030 | 1.410 |
Why?
|
Microbiota | 4 | 2022 | 381 | 1.280 |
Why?
|
RNA, Transfer, Amino Acyl | 4 | 2017 | 11 | 1.260 |
Why?
|
Oligonucleotide Array Sequence Analysis | 9 | 2016 | 689 | 1.180 |
Why?
|
Saccharomyces cerevisiae | 13 | 2023 | 434 | 1.180 |
Why?
|
Substrate Specificity | 25 | 2016 | 347 | 1.160 |
Why?
|
Humans | 100 | 2023 | 86601 | 1.140 |
Why?
|
Models, Molecular | 22 | 2017 | 1286 | 1.100 |
Why?
|
Genetic Code | 6 | 2017 | 25 | 1.080 |
Why?
|
Adaptation, Biological | 2 | 2016 | 85 | 1.080 |
Why?
|
RNA, Transfer, Phe | 12 | 2010 | 18 | 1.080 |
Why?
|
Methyltransferases | 6 | 2020 | 182 | 1.070 |
Why?
|
Methylation | 13 | 2022 | 251 | 1.050 |
Why?
|
Amino Acyl-tRNA Synthetases | 5 | 2020 | 14 | 1.020 |
Why?
|
Animals | 44 | 2023 | 26581 | 0.950 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2021 | 85 | 0.950 |
Why?
|
RNA Stability | 9 | 2020 | 86 | 0.930 |
Why?
|
RNA, Ribosomal | 3 | 2019 | 60 | 0.930 |
Why?
|
Milk | 1 | 2023 | 53 | 0.920 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2023 | 34 | 0.910 |
Why?
|
Mutation | 15 | 2023 | 3967 | 0.880 |
Why?
|
Epigenesis, Genetic | 4 | 2016 | 479 | 0.870 |
Why?
|
Mutation, Missense | 1 | 2023 | 276 | 0.850 |
Why?
|
Nanopores | 1 | 2021 | 6 | 0.840 |
Why?
|
RNA Folding | 2 | 2012 | 7 | 0.840 |
Why?
|
5-Methylcytosine | 3 | 2020 | 112 | 0.840 |
Why?
|
Sequence Analysis, RNA | 8 | 2022 | 217 | 0.840 |
Why?
|
Interferons | 2 | 2021 | 133 | 0.820 |
Why?
|
Diamines | 1 | 2021 | 11 | 0.820 |
Why?
|
AlkB Enzymes | 2 | 2021 | 3 | 0.820 |
Why?
|
Directed Molecular Evolution | 1 | 2021 | 20 | 0.790 |
Why?
|
Histone Deacetylases | 1 | 2021 | 63 | 0.780 |
Why?
|
Mixed Function Oxygenases | 1 | 2021 | 68 | 0.770 |
Why?
|
Proteins | 6 | 2017 | 777 | 0.770 |
Why?
|
Leukemia Virus, Murine | 1 | 2020 | 18 | 0.760 |
Why?
|
Cell Line, Tumor | 11 | 2023 | 2426 | 0.750 |
Why?
|
Gels | 1 | 2020 | 48 | 0.750 |
Why?
|
Nucleic Acid Hybridization | 6 | 2010 | 245 | 0.740 |
Why?
|
Protein Binding | 15 | 2021 | 1456 | 0.720 |
Why?
|
Cochlear Implantation | 5 | 2023 | 31 | 0.720 |
Why?
|
RNA, Transfer, Amino Acid-Specific | 2 | 2016 | 2 | 0.680 |
Why?
|
Gene Expression Regulation | 7 | 2021 | 1920 | 0.670 |
Why?
|
RNA, Transfer, Met | 2 | 2015 | 6 | 0.650 |
Why?
|
Magnesium | 13 | 2008 | 177 | 0.650 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2019 | 273 | 0.650 |
Why?
|
Guanosine | 2 | 2021 | 29 | 0.640 |
Why?
|
Kinetics | 19 | 2014 | 1513 | 0.630 |
Why?
|
Peptide Chain Initiation, Translational | 4 | 2016 | 18 | 0.630 |
Why?
|
Binding Sites | 13 | 2021 | 1098 | 0.620 |
Why?
|
Fluorescent Dyes | 3 | 2016 | 242 | 0.610 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 589 | 0.590 |
Why?
|
Aptamers, Nucleotide | 2 | 2018 | 23 | 0.580 |
Why?
|
Microarray Analysis | 1 | 2016 | 96 | 0.570 |
Why?
|
Cochlear Implants | 3 | 2023 | 33 | 0.570 |
Why?
|
Gene Library | 2 | 2015 | 130 | 0.570 |
Why?
|
Protein Folding | 6 | 2007 | 280 | 0.570 |
Why?
|
Oxidative Stress | 4 | 2013 | 447 | 0.560 |
Why?
|
Methionine-tRNA Ligase | 5 | 2017 | 8 | 0.560 |
Why?
|
Chromatography, Thin Layer | 1 | 2016 | 32 | 0.560 |
Why?
|
Aeropyrum | 1 | 2015 | 2 | 0.560 |
Why?
|
Mice | 20 | 2022 | 11352 | 0.560 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2015 | 21 | 0.550 |
Why?
|
Archaeal Proteins | 1 | 2015 | 18 | 0.550 |
Why?
|
Cell Line | 9 | 2024 | 2468 | 0.540 |
Why?
|
Ribosomes | 5 | 2017 | 111 | 0.540 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group C | 1 | 2015 | 3 | 0.530 |
Why?
|
Prions | 2 | 2005 | 54 | 0.520 |
Why?
|
Gene Expression Regulation, Bacterial | 4 | 2012 | 204 | 0.510 |
Why?
|
Temperature | 2 | 2015 | 396 | 0.500 |
Why?
|
Breast Neoplasms | 4 | 2013 | 2887 | 0.500 |
Why?
|
Acylation | 4 | 2018 | 38 | 0.500 |
Why?
|
DNA, Complementary | 4 | 2021 | 393 | 0.490 |
Why?
|
RNA, Untranslated | 3 | 2018 | 63 | 0.490 |
Why?
|
Structure-Activity Relationship | 7 | 2021 | 408 | 0.490 |
Why?
|
Reverse Transcription | 4 | 2019 | 14 | 0.480 |
Why?
|
Aminoacylation | 4 | 2023 | 5 | 0.480 |
Why?
|
Genomics | 2 | 2018 | 720 | 0.480 |
Why?
|
5' Untranslated Regions | 2 | 2016 | 49 | 0.460 |
Why?
|
Staining and Labeling | 1 | 2013 | 165 | 0.460 |
Why?
|
Saccharomyces cerevisiae Proteins | 5 | 2015 | 276 | 0.450 |
Why?
|
RNA, Transfer, Ser | 1 | 2012 | 2 | 0.450 |
Why?
|
Glycosylation | 3 | 2021 | 129 | 0.440 |
Why?
|
Riboswitch | 1 | 2012 | 5 | 0.430 |
Why?
|
Protein Conformation | 5 | 2011 | 881 | 0.430 |
Why?
|
Aspartate-tRNA Ligase | 1 | 2011 | 1 | 0.420 |
Why?
|
RNA, Transfer, Asp | 1 | 2011 | 1 | 0.420 |
Why?
|
Codon, Nonsense | 1 | 2012 | 41 | 0.420 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2012 | 53 | 0.410 |
Why?
|
Alu Elements | 1 | 2011 | 15 | 0.410 |
Why?
|
3' Untranslated Regions | 1 | 2011 | 92 | 0.400 |
Why?
|
Thermodynamics | 13 | 2008 | 309 | 0.390 |
Why?
|
Circadian Clocks | 2 | 2022 | 53 | 0.390 |
Why?
|
Adaptation, Physiological | 1 | 2013 | 306 | 0.390 |
Why?
|
Catalysis | 11 | 2010 | 203 | 0.390 |
Why?
|
Apoptosis | 6 | 2021 | 1683 | 0.390 |
Why?
|
Charcot-Marie-Tooth Disease | 2 | 2021 | 5 | 0.380 |
Why?
|
Membrane Transport Proteins | 1 | 2012 | 166 | 0.380 |
Why?
|
Genome | 4 | 2012 | 372 | 0.380 |
Why?
|
Gastrointestinal Microbiome | 1 | 2017 | 455 | 0.380 |
Why?
|
HIV-1 | 4 | 2020 | 163 | 0.370 |
Why?
|
Oligonucleotides | 2 | 2009 | 92 | 0.360 |
Why?
|
MCF-7 Cells | 2 | 2020 | 106 | 0.360 |
Why?
|
Cluster Analysis | 2 | 2023 | 369 | 0.350 |
Why?
|
Proteasome Inhibitors | 1 | 2009 | 51 | 0.350 |
Why?
|
Boronic Acids | 1 | 2009 | 55 | 0.340 |
Why?
|
Catalytic Domain | 8 | 2015 | 156 | 0.340 |
Why?
|
Mitochondria | 4 | 2021 | 535 | 0.340 |
Why?
|
Protease Inhibitors | 1 | 2009 | 72 | 0.340 |
Why?
|
Alternative Splicing | 4 | 2019 | 201 | 0.340 |
Why?
|
Water Pollutants, Chemical | 2 | 2020 | 135 | 0.340 |
Why?
|
DNA-Directed RNA Polymerases | 2 | 2009 | 102 | 0.340 |
Why?
|
PrPSc Proteins | 2 | 2005 | 22 | 0.340 |
Why?
|
Bacteria | 3 | 2022 | 447 | 0.340 |
Why?
|
Genome, Human | 1 | 2013 | 756 | 0.340 |
Why?
|
Sequence Alignment | 3 | 2018 | 351 | 0.330 |
Why?
|
Pyrazines | 1 | 2009 | 92 | 0.330 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 2 | 2019 | 19 | 0.330 |
Why?
|
Speech Perception | 2 | 2022 | 71 | 0.330 |
Why?
|
Virus Replication | 3 | 2020 | 319 | 0.330 |
Why?
|
Stomach Neoplasms | 3 | 2023 | 266 | 0.330 |
Why?
|
DNA Methylation | 3 | 2021 | 628 | 0.330 |
Why?
|
Gene Expression Profiling | 5 | 2023 | 1384 | 0.320 |
Why?
|
Genome, Fungal | 2 | 2023 | 32 | 0.320 |
Why?
|
RNA, Fungal | 4 | 2007 | 42 | 0.320 |
Why?
|
Urea | 7 | 2001 | 57 | 0.320 |
Why?
|
Cecum | 2 | 2018 | 68 | 0.310 |
Why?
|
Organ Specificity | 2 | 2016 | 258 | 0.310 |
Why?
|
Ribonuclease, Pancreatic | 4 | 2018 | 24 | 0.310 |
Why?
|
Immunity, Innate | 2 | 2012 | 409 | 0.300 |
Why?
|
Algorithms | 1 | 2015 | 1830 | 0.300 |
Why?
|
Models, Chemical | 7 | 2007 | 178 | 0.290 |
Why?
|
Cell Proliferation | 6 | 2021 | 1578 | 0.290 |
Why?
|
RNA Cleavage | 2 | 2018 | 7 | 0.290 |
Why?
|
Models, Biological | 3 | 2011 | 1749 | 0.290 |
Why?
|
Genetic Variation | 3 | 2023 | 1351 | 0.290 |
Why?
|
Mammals | 3 | 2022 | 227 | 0.280 |
Why?
|
Genetic Techniques | 1 | 2006 | 72 | 0.280 |
Why?
|
RNA, Viral | 3 | 2020 | 327 | 0.280 |
Why?
|
Ribonucleoproteins | 3 | 2014 | 38 | 0.280 |
Why?
|
Holoenzymes | 6 | 2010 | 10 | 0.270 |
Why?
|
Nucleotide Motifs | 3 | 2015 | 47 | 0.270 |
Why?
|
Phylogeny | 8 | 2017 | 1137 | 0.270 |
Why?
|
Cell Nucleus | 4 | 2013 | 579 | 0.270 |
Why?
|
Amino Acid Sequence | 4 | 2019 | 2062 | 0.260 |
Why?
|
Multiple Myeloma | 1 | 2009 | 307 | 0.260 |
Why?
|
Evolution, Molecular | 5 | 2023 | 813 | 0.260 |
Why?
|
Prion Diseases | 1 | 2005 | 32 | 0.260 |
Why?
|
Computational Biology | 2 | 2022 | 528 | 0.260 |
Why?
|
Models, Genetic | 5 | 2017 | 926 | 0.250 |
Why?
|
DNA | 3 | 2021 | 1294 | 0.250 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 376 | 0.250 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 2 | 2015 | 17 | 0.250 |
Why?
|
Drosophila | 2 | 2021 | 498 | 0.250 |
Why?
|
Transcription Factors | 3 | 2020 | 1565 | 0.250 |
Why?
|
Peptide Elongation Factors | 2 | 2005 | 28 | 0.240 |
Why?
|
Hydroxyl Radical | 6 | 2002 | 35 | 0.240 |
Why?
|
Chromosomes, Artificial, Yeast | 1 | 2023 | 37 | 0.240 |
Why?
|
Evodia | 1 | 2023 | 1 | 0.240 |
Why?
|
Drug Design | 2 | 2021 | 124 | 0.240 |
Why?
|
Pancreatic Diseases | 1 | 2023 | 52 | 0.240 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2023 | 592 | 0.240 |
Why?
|
Plants, Medicinal | 1 | 2023 | 42 | 0.240 |
Why?
|
Discriminant Analysis | 1 | 2023 | 66 | 0.230 |
Why?
|
Least-Squares Analysis | 1 | 2023 | 48 | 0.230 |
Why?
|
Base Pairing | 3 | 2016 | 55 | 0.230 |
Why?
|
Circular Dichroism | 9 | 2010 | 117 | 0.230 |
Why?
|
Food Contamination | 1 | 2023 | 31 | 0.230 |
Why?
|
Bacterial Proteins | 5 | 2013 | 864 | 0.230 |
Why?
|
Testosterone | 2 | 2022 | 271 | 0.230 |
Why?
|
Inverted Repeat Sequences | 2 | 2013 | 9 | 0.230 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 1074 | 0.230 |
Why?
|
Periodic Acid | 1 | 2022 | 4 | 0.220 |
Why?
|
Plasmodium yoelii | 1 | 2022 | 4 | 0.220 |
Why?
|
Neoplasms | 3 | 2023 | 2897 | 0.220 |
Why?
|
Sulfur | 1 | 2022 | 28 | 0.220 |
Why?
|
Malaria | 1 | 2022 | 23 | 0.220 |
Why?
|
Powders | 1 | 2023 | 74 | 0.220 |
Why?
|
Ecology | 1 | 2023 | 74 | 0.220 |
Why?
|
Leydig Cells | 1 | 2022 | 11 | 0.220 |
Why?
|
Intrinsically Disordered Proteins | 1 | 2022 | 8 | 0.220 |
Why?
|
Genome-Wide Association Study | 1 | 2010 | 1620 | 0.220 |
Why?
|
Nuclear Proteins | 2 | 2020 | 696 | 0.210 |
Why?
|
Codon, Terminator | 2 | 2013 | 21 | 0.210 |
Why?
|
Gastrointestinal Diseases | 1 | 2023 | 146 | 0.210 |
Why?
|
Regulon | 1 | 2021 | 16 | 0.210 |
Why?
|
Hydrolysis | 5 | 2001 | 141 | 0.210 |
Why?
|
Ossicular Prosthesis | 1 | 2021 | 5 | 0.210 |
Why?
|
Ossicular Replacement | 1 | 2021 | 6 | 0.210 |
Why?
|
Alanine-tRNA Ligase | 1 | 2021 | 1 | 0.200 |
Why?
|
Neuropilin-1 | 1 | 2021 | 14 | 0.200 |
Why?
|
Protein Transport | 2 | 2015 | 411 | 0.200 |
Why?
|
Lead | 1 | 2001 | 26 | 0.200 |
Why?
|
Mutagenesis | 3 | 2013 | 199 | 0.200 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2021 | 78 | 0.200 |
Why?
|
Fluorometry | 1 | 2021 | 30 | 0.200 |
Why?
|
Recidivism | 1 | 2021 | 2 | 0.200 |
Why?
|
Mastoidectomy | 1 | 2021 | 2 | 0.200 |
Why?
|
Cell Cycle Checkpoints | 1 | 2021 | 63 | 0.200 |
Why?
|
Gastroscopy | 1 | 2021 | 23 | 0.200 |
Why?
|
Biochemistry | 1 | 2001 | 27 | 0.200 |
Why?
|
Cholesteatoma, Middle Ear | 1 | 2021 | 8 | 0.200 |
Why?
|
Cholesteatoma | 1 | 2021 | 7 | 0.200 |
Why?
|
Magnets | 1 | 2021 | 14 | 0.200 |
Why?
|
Conservative Treatment | 1 | 2021 | 20 | 0.200 |
Why?
|
RNA-Directed DNA Polymerase | 2 | 2018 | 16 | 0.190 |
Why?
|
Water Purification | 1 | 2020 | 3 | 0.190 |
Why?
|
RNA, Transfer, Lys | 2 | 2018 | 3 | 0.190 |
Why?
|
Polyphenols | 1 | 2020 | 13 | 0.190 |
Why?
|
Emergency Treatment | 1 | 2021 | 39 | 0.190 |
Why?
|
DNA-Activated Protein Kinase | 1 | 2020 | 16 | 0.190 |
Why?
|
Mutagenesis, Site-Directed | 3 | 2009 | 279 | 0.190 |
Why?
|
Alanine | 2 | 2020 | 85 | 0.190 |
Why?
|
Protein Structure, Tertiary | 4 | 2011 | 736 | 0.190 |
Why?
|
Mitochondrial Proteins | 1 | 2021 | 123 | 0.190 |
Why?
|
Bacteroidetes | 2 | 2018 | 37 | 0.190 |
Why?
|
Suppuration | 1 | 2020 | 9 | 0.190 |
Why?
|
Hydro-Lyases | 1 | 2020 | 6 | 0.190 |
Why?
|
Abdomen | 1 | 2021 | 122 | 0.190 |
Why?
|
HIV Protease | 1 | 2020 | 10 | 0.190 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 153 | 0.190 |
Why?
|
NIH 3T3 Cells | 1 | 2020 | 105 | 0.190 |
Why?
|
Genome, Viral | 1 | 2020 | 74 | 0.190 |
Why?
|
Foreign Bodies | 1 | 2021 | 63 | 0.180 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2017 | 268 | 0.180 |
Why?
|
RNA Editing | 1 | 2020 | 34 | 0.180 |
Why?
|
Bromates | 1 | 2019 | 1 | 0.180 |
Why?
|
Esophageal Neoplasms | 1 | 2022 | 321 | 0.180 |
Why?
|
Retroviridae | 1 | 2020 | 79 | 0.180 |
Why?
|
Environmental Pollutants | 1 | 2020 | 51 | 0.180 |
Why?
|
Polybrominated Biphenyls | 1 | 2019 | 5 | 0.180 |
Why?
|
Phosphorylation | 7 | 2013 | 1106 | 0.180 |
Why?
|
Histidine-tRNA Ligase | 1 | 2019 | 1 | 0.180 |
Why?
|
Genetics, Population | 1 | 2023 | 394 | 0.180 |
Why?
|
Sodium | 1 | 2001 | 341 | 0.180 |
Why?
|
Caenorhabditis elegans | 1 | 2021 | 223 | 0.180 |
Why?
|
Machine Learning | 1 | 2021 | 232 | 0.180 |
Why?
|
Lung Neoplasms | 2 | 2023 | 2261 | 0.180 |
Why?
|
Eukaryotic Initiation Factor-2 | 4 | 2013 | 15 | 0.180 |
Why?
|
RNA, Small Nuclear | 1 | 2019 | 32 | 0.170 |
Why?
|
Blotting, Northern | 2 | 2017 | 256 | 0.170 |
Why?
|
Ceftriaxone | 1 | 2019 | 9 | 0.170 |
Why?
|
RNA, Ribosomal, 28S | 1 | 2018 | 11 | 0.170 |
Why?
|
Molecular Dynamics Simulation | 1 | 2021 | 245 | 0.170 |
Why?
|
Anemia, Hemolytic | 1 | 2019 | 19 | 0.170 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 879 | 0.170 |
Why?
|
DNA Damage | 1 | 2021 | 366 | 0.170 |
Why?
|
Cell Differentiation | 2 | 2024 | 1458 | 0.170 |
Why?
|
Gene Expression | 2 | 2021 | 1284 | 0.170 |
Why?
|
CME-Carbodiimide | 1 | 2018 | 1 | 0.170 |
Why?
|
Base Composition | 4 | 2022 | 35 | 0.170 |
Why?
|
Base Pair Mismatch | 2 | 2013 | 27 | 0.160 |
Why?
|
Thermotoga maritima | 2 | 2010 | 15 | 0.160 |
Why?
|
Pyrimidines | 1 | 2021 | 370 | 0.160 |
Why?
|
Amination | 1 | 2018 | 5 | 0.160 |
Why?
|
Biomedical Research | 1 | 2022 | 375 | 0.160 |
Why?
|
Endoplasmic Reticulum Stress | 2 | 2022 | 83 | 0.160 |
Why?
|
Deafness | 2 | 2015 | 47 | 0.160 |
Why?
|
Meckel Diverticulum | 1 | 2017 | 6 | 0.160 |
Why?
|
Ribonucleases | 1 | 2018 | 92 | 0.160 |
Why?
|
Cisplatin | 1 | 2020 | 612 | 0.160 |
Why?
|
RNA Probes | 2 | 2016 | 16 | 0.160 |
Why?
|
Proteomics | 2 | 2023 | 212 | 0.160 |
Why?
|
Cell Movement | 1 | 2021 | 758 | 0.150 |
Why?
|
Crystallography, X-Ray | 7 | 2021 | 485 | 0.150 |
Why?
|
Argonaute Proteins | 1 | 2017 | 10 | 0.150 |
Why?
|
Oxidation-Reduction | 4 | 2020 | 373 | 0.150 |
Why?
|
Biocatalysis | 2 | 2015 | 51 | 0.150 |
Why?
|
Open Reading Frames | 2 | 2014 | 117 | 0.150 |
Why?
|
Demethylation | 1 | 2017 | 9 | 0.150 |
Why?
|
Nucleotides | 3 | 2017 | 95 | 0.150 |
Why?
|
Firmicutes | 1 | 2017 | 14 | 0.150 |
Why?
|
Disease | 1 | 2018 | 90 | 0.150 |
Why?
|
AlkB Homolog 1, Histone H2a Dioxygenase | 1 | 2016 | 3 | 0.150 |
Why?
|
Printing | 1 | 2016 | 4 | 0.150 |
Why?
|
Sulfur Radioisotopes | 1 | 2016 | 22 | 0.150 |
Why?
|
Anaerobiosis | 1 | 2016 | 22 | 0.150 |
Why?
|
Carbon Radioisotopes | 1 | 2016 | 35 | 0.150 |
Why?
|
Tritium | 1 | 2016 | 133 | 0.150 |
Why?
|
Brain | 3 | 2018 | 2216 | 0.150 |
Why?
|
Codon, Initiator | 2 | 2016 | 21 | 0.140 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2016 | 14 | 0.140 |
Why?
|
RNA Transport | 2 | 2013 | 11 | 0.140 |
Why?
|
Peroxides | 3 | 2020 | 12 | 0.140 |
Why?
|
Immunotherapy | 1 | 2021 | 629 | 0.140 |
Why?
|
Viral Proteins | 2 | 2012 | 300 | 0.140 |
Why?
|
RNA, Transfer, Glu | 1 | 2016 | 3 | 0.140 |
Why?
|
Citrate (si)-Synthase | 1 | 2015 | 2 | 0.140 |
Why?
|
Radioisotopes | 1 | 2016 | 45 | 0.140 |
Why?
|
Lysine | 1 | 2016 | 147 | 0.140 |
Why?
|
Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 2 | 2013 | 41 | 0.140 |
Why?
|
Mice, Nude | 2 | 2020 | 790 | 0.140 |
Why?
|
Thermus thermophilus | 2 | 2006 | 10 | 0.140 |
Why?
|
Child | 7 | 2023 | 6926 | 0.140 |
Why?
|
Speech Intelligibility | 1 | 2015 | 10 | 0.130 |
Why?
|
Organophosphorus Compounds | 2 | 2011 | 55 | 0.130 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2007 | 63 | 0.130 |
Why?
|
Metals | 3 | 2023 | 90 | 0.130 |
Why?
|
Epigenomics | 1 | 2016 | 100 | 0.130 |
Why?
|
Heat-Shock Response | 1 | 2015 | 46 | 0.130 |
Why?
|
Recombinant Proteins | 3 | 2021 | 1014 | 0.130 |
Why?
|
Immunoprecipitation | 1 | 2015 | 134 | 0.130 |
Why?
|
Cross-Linking Reagents | 1 | 2015 | 86 | 0.130 |
Why?
|
Amino Acid Substitution | 1 | 2015 | 339 | 0.130 |
Why?
|
Apoptosomes | 1 | 2014 | 2 | 0.120 |
Why?
|
tRNA Methyltransferases | 2 | 2012 | 12 | 0.120 |
Why?
|
Adenine | 1 | 2014 | 85 | 0.120 |
Why?
|
Cytochromes c | 1 | 2014 | 27 | 0.120 |
Why?
|
Genome, Insect | 1 | 2014 | 75 | 0.120 |
Why?
|
Treatment Outcome | 7 | 2023 | 7988 | 0.120 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 728 | 0.120 |
Why?
|
Ultraviolet Rays | 2 | 2014 | 193 | 0.120 |
Why?
|
Dimerization | 2 | 2005 | 143 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2012 | 182 | 0.120 |
Why?
|
Male | 15 | 2022 | 40956 | 0.120 |
Why?
|
Plasmids | 2 | 2012 | 287 | 0.120 |
Why?
|
Consensus Sequence | 1 | 2013 | 64 | 0.120 |
Why?
|
Frameshifting, Ribosomal | 1 | 2013 | 5 | 0.120 |
Why?
|
Bothrops | 1 | 2013 | 1 | 0.120 |
Why?
|
Testis | 2 | 2021 | 152 | 0.120 |
Why?
|
Spleen | 2 | 2022 | 430 | 0.120 |
Why?
|
Conserved Sequence | 5 | 2017 | 210 | 0.120 |
Why?
|
Retrospective Studies | 6 | 2023 | 8475 | 0.120 |
Why?
|
Genome, Mitochondrial | 1 | 2013 | 26 | 0.120 |
Why?
|
Biological Evolution | 2 | 2012 | 918 | 0.120 |
Why?
|
Digestive System Neoplasms | 2 | 2004 | 20 | 0.110 |
Why?
|
Lymph Nodes | 2 | 2007 | 530 | 0.110 |
Why?
|
Molecular Docking Simulation | 1 | 2013 | 46 | 0.110 |
Why?
|
Tryptophan | 2 | 2010 | 90 | 0.110 |
Why?
|
Cochlear Nerve | 1 | 2013 | 9 | 0.110 |
Why?
|
Databases, Protein | 1 | 2013 | 52 | 0.110 |
Why?
|
Vaccinia virus | 1 | 2012 | 19 | 0.110 |
Why?
|
Transcriptional Elongation Factors | 2 | 2005 | 23 | 0.110 |
Why?
|
Stem Cell Factor | 1 | 2012 | 19 | 0.110 |
Why?
|
Yeasts | 3 | 2007 | 49 | 0.110 |
Why?
|
Ferrous Compounds | 3 | 1998 | 17 | 0.110 |
Why?
|
Erythroid Precursor Cells | 1 | 2012 | 32 | 0.110 |
Why?
|
Fungal Proteins | 1 | 2013 | 141 | 0.110 |
Why?
|
RNA, Transfer, Leu | 1 | 2012 | 11 | 0.110 |
Why?
|
Edetic Acid | 3 | 1998 | 43 | 0.110 |
Why?
|
Nanotechnology | 1 | 2013 | 68 | 0.110 |
Why?
|
Erythropoietin | 1 | 2012 | 91 | 0.110 |
Why?
|
Cobamides | 1 | 2012 | 2 | 0.110 |
Why?
|
RNA Polymerase I | 1 | 2012 | 3 | 0.110 |
Why?
|
Liver Neoplasms | 1 | 2018 | 735 | 0.110 |
Why?
|
Gastrectomy | 1 | 2012 | 68 | 0.110 |
Why?
|
Forecasting | 1 | 2013 | 304 | 0.110 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2012 | 90 | 0.110 |
Why?
|
Influenza A virus | 1 | 2012 | 169 | 0.100 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2012 | 173 | 0.100 |
Why?
|
Osmolar Concentration | 1 | 2012 | 181 | 0.100 |
Why?
|
Diethyl Pyrocarbonate | 2 | 2001 | 5 | 0.100 |
Why?
|
Digestive System Surgical Procedures | 2 | 2004 | 120 | 0.100 |
Why?
|
Protein Subunits | 2 | 2002 | 122 | 0.100 |
Why?
|
Genes, Reporter | 2 | 2009 | 268 | 0.100 |
Why?
|
RNA Splicing | 1 | 2013 | 142 | 0.100 |
Why?
|
Siloxanes | 1 | 2011 | 5 | 0.100 |
Why?
|
Styrenes | 1 | 2011 | 7 | 0.100 |
Why?
|
Tympanoplasty | 2 | 2021 | 13 | 0.100 |
Why?
|
Green Fluorescent Proteins | 2 | 2009 | 305 | 0.100 |
Why?
|
Geobacillus stearothermophilus | 3 | 2008 | 10 | 0.100 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 746 | 0.100 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2012 | 148 | 0.100 |
Why?
|
DNA Repair Enzymes | 1 | 2011 | 52 | 0.100 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2012 | 203 | 0.100 |
Why?
|
Antigen Presentation | 1 | 2012 | 209 | 0.100 |
Why?
|
Uridine | 1 | 2010 | 56 | 0.100 |
Why?
|
Oligodeoxyribonucleotides | 2 | 2004 | 126 | 0.100 |
Why?
|
Nucleic Acid Heteroduplexes | 2 | 2001 | 11 | 0.100 |
Why?
|
Neoadjuvant Therapy | 1 | 2013 | 317 | 0.100 |
Why?
|
Transfection | 1 | 2012 | 896 | 0.100 |
Why?
|
Primary Cell Culture | 2 | 2021 | 72 | 0.090 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 645 | 0.090 |
Why?
|
Infant | 4 | 2021 | 3045 | 0.090 |
Why?
|
Spectrometry, Fluorescence | 4 | 2005 | 85 | 0.090 |
Why?
|
Cytosine | 1 | 2011 | 127 | 0.090 |
Why?
|
Ribonuclease T1 | 2 | 1999 | 7 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2436 | 0.090 |
Why?
|
Selection, Genetic | 2 | 2014 | 502 | 0.090 |
Why?
|
Arginine | 1 | 2010 | 136 | 0.090 |
Why?
|
Child, Preschool | 4 | 2021 | 3611 | 0.090 |
Why?
|
Genes, Neoplasm | 1 | 2009 | 37 | 0.090 |
Why?
|
Nitrogen | 1 | 2010 | 70 | 0.090 |
Why?
|
Cryoelectron Microscopy | 1 | 2010 | 91 | 0.090 |
Why?
|
Orthomyxoviridae | 1 | 2009 | 37 | 0.090 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 2357 | 0.090 |
Why?
|
Transcriptional Activation | 2 | 2013 | 280 | 0.090 |
Why?
|
Laparoscopy | 2 | 2017 | 754 | 0.090 |
Why?
|
Insulin-Secreting Cells | 1 | 2013 | 397 | 0.090 |
Why?
|
eIF-2 Kinase | 1 | 2009 | 46 | 0.090 |
Why?
|
NADPH Oxidases | 1 | 2009 | 81 | 0.090 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2013 | 382 | 0.090 |
Why?
|
Bortezomib | 1 | 2009 | 76 | 0.090 |
Why?
|
Toll-Like Receptors | 1 | 2009 | 92 | 0.090 |
Why?
|
ErbB Receptors | 2 | 2023 | 485 | 0.080 |
Why?
|
Sensitivity and Specificity | 4 | 2007 | 1990 | 0.080 |
Why?
|
Hot Temperature | 2 | 2002 | 206 | 0.080 |
Why?
|
Female | 11 | 2021 | 44507 | 0.080 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2000 | 493 | 0.080 |
Why?
|
Protons | 2 | 1999 | 98 | 0.080 |
Why?
|
Ligands | 1 | 2009 | 433 | 0.080 |
Why?
|
Adenoviridae | 1 | 2009 | 345 | 0.080 |
Why?
|
Hydrogen Bonding | 3 | 2004 | 144 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2020 | 458 | 0.080 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2008 | 94 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 379 | 0.080 |
Why?
|
Breast | 1 | 2009 | 286 | 0.080 |
Why?
|
Technetium Tc 99m Sulfur Colloid | 1 | 2007 | 11 | 0.080 |
Why?
|
Vulva | 1 | 2006 | 23 | 0.070 |
Why?
|
Nucleic Acid Denaturation | 3 | 2001 | 34 | 0.070 |
Why?
|
Reactive Oxygen Species | 1 | 2009 | 480 | 0.070 |
Why?
|
Cells, Cultured | 3 | 2021 | 2818 | 0.070 |
Why?
|
Brain Chemistry | 1 | 2006 | 121 | 0.070 |
Why?
|
Evaluation Studies as Topic | 1 | 2006 | 274 | 0.070 |
Why?
|
Radiopharmaceuticals | 1 | 2007 | 179 | 0.070 |
Why?
|
Species Specificity | 3 | 2013 | 678 | 0.070 |
Why?
|
Endopeptidase K | 1 | 2005 | 12 | 0.070 |
Why?
|
Lymphatic Metastasis | 2 | 2007 | 481 | 0.070 |
Why?
|
Gene Dosage | 1 | 2006 | 207 | 0.070 |
Why?
|
DNA Primers | 2 | 1998 | 543 | 0.070 |
Why?
|
Thymus Gland | 1 | 2006 | 195 | 0.070 |
Why?
|
Dogs | 1 | 2006 | 685 | 0.070 |
Why?
|
Molecular Motor Proteins | 1 | 2006 | 31 | 0.070 |
Why?
|
Molecular Weight | 1 | 2005 | 332 | 0.070 |
Why?
|
Scattering, Radiation | 2 | 2002 | 114 | 0.070 |
Why?
|
X-Rays | 2 | 2002 | 130 | 0.070 |
Why?
|
RNA, Small Interfering | 2 | 2017 | 547 | 0.070 |
Why?
|
Polyribosomes | 2 | 2016 | 18 | 0.070 |
Why?
|
PrPC Proteins | 1 | 2005 | 13 | 0.060 |
Why?
|
Computer Simulation | 2 | 2007 | 1078 | 0.060 |
Why?
|
Obesity | 1 | 2011 | 963 | 0.060 |
Why?
|
Cloning, Molecular | 2 | 1996 | 646 | 0.060 |
Why?
|
Gene Knockdown Techniques | 2 | 2017 | 236 | 0.060 |
Why?
|
Molecular Structure | 2 | 2019 | 287 | 0.060 |
Why?
|
Rifampin | 1 | 2004 | 22 | 0.060 |
Why?
|
Mice, Inbred C57BL | 3 | 2018 | 3092 | 0.060 |
Why?
|
Sodium Chloride | 2 | 2009 | 86 | 0.060 |
Why?
|
Phospholipase C gamma | 1 | 2023 | 15 | 0.060 |
Why?
|
Indole Alkaloids | 1 | 2023 | 3 | 0.060 |
Why?
|
Phenotype | 1 | 2010 | 2377 | 0.060 |
Why?
|
Synthetic Biology | 1 | 2023 | 15 | 0.060 |
Why?
|
Erlotinib Hydrochloride | 1 | 2023 | 90 | 0.060 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 1373 | 0.060 |
Why?
|
Oligoribonucleotides | 2 | 2017 | 28 | 0.060 |
Why?
|
Ultrasonography, Interventional | 1 | 2023 | 121 | 0.060 |
Why?
|
Fruit | 1 | 2023 | 75 | 0.060 |
Why?
|
Oceans and Seas | 1 | 2023 | 30 | 0.060 |
Why?
|
Receptors, KIR2DL1 | 1 | 2022 | 4 | 0.060 |
Why?
|
Fusobacterium nucleatum | 1 | 2022 | 4 | 0.060 |
Why?
|
Organic Chemicals | 1 | 2023 | 33 | 0.060 |
Why?
|
Endosonography | 1 | 2023 | 96 | 0.060 |
Why?
|
Muscle Contraction | 1 | 2004 | 283 | 0.060 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2023 | 29 | 0.060 |
Why?
|
Drainage | 1 | 2023 | 157 | 0.060 |
Why?
|
Cochlea | 1 | 2023 | 50 | 0.060 |
Why?
|
Sulfites | 1 | 2022 | 26 | 0.060 |
Why?
|
Replantation | 1 | 2023 | 36 | 0.060 |
Why?
|
Hyperplasia | 1 | 2023 | 148 | 0.060 |
Why?
|
Tetrahymena | 1 | 2002 | 37 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2014 | 927 | 0.050 |
Why?
|
Protein Interaction Maps | 1 | 2022 | 48 | 0.050 |
Why?
|
Oncogenes | 1 | 2022 | 88 | 0.050 |
Why?
|
Manubrium | 1 | 2021 | 1 | 0.050 |
Why?
|
Tensor Tympani | 1 | 2021 | 1 | 0.050 |
Why?
|
Heparin | 1 | 2023 | 175 | 0.050 |
Why?
|
Evoked Potentials, Auditory | 1 | 2022 | 37 | 0.050 |
Why?
|
Malleus | 1 | 2021 | 4 | 0.050 |
Why?
|
CLOCK Proteins | 1 | 2021 | 15 | 0.050 |
Why?
|
Apolipoproteins | 1 | 2021 | 38 | 0.050 |
Why?
|
Hydrogen Peroxide | 1 | 2022 | 158 | 0.050 |
Why?
|
Cytidine | 1 | 2021 | 17 | 0.050 |
Why?
|
Tendons | 1 | 2021 | 44 | 0.050 |
Why?
|
Immunity | 1 | 2022 | 136 | 0.050 |
Why?
|
Speech | 1 | 2022 | 84 | 0.050 |
Why?
|
RNA Ligase (ATP) | 1 | 2001 | 3 | 0.050 |
Why?
|
Nucleic Acid Renaturation | 1 | 2001 | 5 | 0.050 |
Why?
|
Exonucleases | 1 | 2001 | 8 | 0.050 |
Why?
|
Phosphorus Radioisotopes | 1 | 2001 | 19 | 0.050 |
Why?
|
Hep G2 Cells | 1 | 2021 | 48 | 0.050 |
Why?
|
Cations, Monovalent | 1 | 2001 | 6 | 0.050 |
Why?
|
Liver | 1 | 2006 | 1229 | 0.050 |
Why?
|
Plant Extracts | 1 | 2023 | 244 | 0.050 |
Why?
|
Avidin | 1 | 2001 | 5 | 0.050 |
Why?
|
Cations, Divalent | 1 | 2001 | 39 | 0.050 |
Why?
|
Deuterium Exchange Measurement | 1 | 2021 | 10 | 0.050 |
Why?
|
Hearing | 1 | 2021 | 59 | 0.050 |
Why?
|
Muscles | 1 | 2021 | 194 | 0.050 |
Why?
|
Scattering, Small Angle | 1 | 2021 | 35 | 0.050 |
Why?
|
Chromatography, Gel | 1 | 2001 | 103 | 0.050 |
Why?
|
Ear Canal | 1 | 2021 | 13 | 0.050 |
Why?
|
Cell Survival | 2 | 2014 | 969 | 0.050 |
Why?
|
Stents | 1 | 2023 | 377 | 0.050 |
Why?
|
Biotin | 1 | 2001 | 44 | 0.050 |
Why?
|
Genes, Bacterial | 2 | 2012 | 198 | 0.050 |
Why?
|
Macromolecular Substances | 1 | 2001 | 177 | 0.050 |
Why?
|
Mastoid | 1 | 2021 | 17 | 0.050 |
Why?
|
Prognosis | 2 | 2022 | 3674 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 639 | 0.050 |
Why?
|
Hemorrhage | 1 | 2023 | 268 | 0.050 |
Why?
|
Cattle | 1 | 2001 | 376 | 0.050 |
Why?
|
Protein Domains | 1 | 2021 | 128 | 0.050 |
Why?
|
Threonine | 1 | 2020 | 33 | 0.050 |
Why?
|
Reoperation | 1 | 2023 | 597 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2022 | 860 | 0.050 |
Why?
|
Titrimetry | 1 | 1999 | 15 | 0.050 |
Why?
|
Rats | 1 | 2006 | 3990 | 0.050 |
Why?
|
Time Factors | 4 | 2012 | 5209 | 0.050 |
Why?
|
Tyrosine-tRNA Ligase | 1 | 2019 | 1 | 0.050 |
Why?
|
Gain of Function Mutation | 1 | 2019 | 13 | 0.050 |
Why?
|
Virion | 1 | 2020 | 59 | 0.050 |
Why?
|
Drug Synergism | 1 | 2020 | 303 | 0.050 |
Why?
|
Bacteriophage T7 | 1 | 1999 | 7 | 0.040 |
Why?
|
Hydroxides | 1 | 1999 | 9 | 0.040 |
Why?
|
Iron | 1 | 2020 | 164 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 853 | 0.040 |
Why?
|
Vertebrates | 1 | 2020 | 90 | 0.040 |
Why?
|
Anticoagulants | 1 | 2023 | 408 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 154 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2019 | 116 | 0.040 |
Why?
|
RNA Polymerase II | 1 | 2019 | 55 | 0.040 |
Why?
|
Vestibular Aqueduct | 1 | 2019 | 2 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2005 | 1376 | 0.040 |
Why?
|
MERRF Syndrome | 1 | 2018 | 2 | 0.040 |
Why?
|
DNA Footprinting | 1 | 1998 | 18 | 0.040 |
Why?
|
Lymphocytes | 1 | 2021 | 464 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 559 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2013 | 864 | 0.040 |
Why?
|
Circadian Rhythm | 1 | 2021 | 303 | 0.040 |
Why?
|
Myoblasts | 1 | 2018 | 31 | 0.040 |
Why?
|
Axons | 1 | 2019 | 174 | 0.040 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2019 | 46 | 0.040 |
Why?
|
T-Lymphocytes | 2 | 2017 | 1195 | 0.040 |
Why?
|
Magnesium Chloride | 1 | 1997 | 5 | 0.040 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1997 | 43 | 0.040 |
Why?
|
Laparotomy | 1 | 2017 | 59 | 0.040 |
Why?
|
Exons | 1 | 2019 | 450 | 0.040 |
Why?
|
Protein Denaturation | 1 | 1997 | 106 | 0.040 |
Why?
|
RNA, Transfer, Arg | 1 | 2017 | 2 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 2 | 2012 | 557 | 0.040 |
Why?
|
DNA, Bacterial | 1 | 1998 | 236 | 0.040 |
Why?
|
Endogenous Retroviruses | 1 | 2017 | 10 | 0.040 |
Why?
|
Esters | 1 | 1997 | 29 | 0.040 |
Why?
|
Protein Splicing | 1 | 2017 | 2 | 0.040 |
Why?
|
Oligonucleotides, Antisense | 1 | 2017 | 69 | 0.040 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 425 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 484 | 0.040 |
Why?
|
Carbon | 1 | 1997 | 80 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2022 | 1197 | 0.040 |
Why?
|
Butadienes | 1 | 2016 | 33 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2004 | 1169 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 1047 | 0.040 |
Why?
|
GC Rich Sequence | 1 | 2016 | 8 | 0.040 |
Why?
|
Eubacterium | 1 | 1995 | 2 | 0.040 |
Why?
|
Models, Structural | 1 | 1995 | 58 | 0.030 |
Why?
|
RNA Interference | 1 | 2017 | 369 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2016 | 53 | 0.030 |
Why?
|
Nitriles | 1 | 2016 | 149 | 0.030 |
Why?
|
Antiviral Agents | 1 | 2020 | 510 | 0.030 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2015 | 36 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2018 | 263 | 0.030 |
Why?
|
Cycloheximide | 1 | 2015 | 56 | 0.030 |
Why?
|
Protein Aggregates | 1 | 2015 | 20 | 0.030 |
Why?
|
Cytoplasmic Granules | 1 | 2015 | 94 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 449 | 0.030 |
Why?
|
Thiourea | 1 | 2014 | 8 | 0.030 |
Why?
|
Potassium Chloride | 1 | 1995 | 87 | 0.030 |
Why?
|
Point Mutation | 1 | 1995 | 246 | 0.030 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 74 | 0.030 |
Why?
|
Apoptotic Protease-Activating Factor 1 | 1 | 2014 | 7 | 0.030 |
Why?
|
Osmotic Pressure | 1 | 2014 | 21 | 0.030 |
Why?
|
Caspase 9 | 1 | 2014 | 48 | 0.030 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2014 | 72 | 0.030 |
Why?
|
RNA 3' End Processing | 1 | 2013 | 1 | 0.030 |
Why?
|
Caspase 3 | 1 | 2014 | 159 | 0.030 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2013 | 39 | 0.030 |
Why?
|
RNA Nucleotidyltransferases | 1 | 2013 | 11 | 0.030 |
Why?
|
Amino Acid Transport Systems | 1 | 2013 | 4 | 0.030 |
Why?
|
Glucose | 1 | 2016 | 638 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2005 | 1961 | 0.030 |
Why?
|
Organelles | 1 | 2013 | 52 | 0.030 |
Why?
|
Activating Transcription Factor 4 | 1 | 2013 | 15 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 1565 | 0.030 |
Why?
|
Auditory Threshold | 1 | 2013 | 17 | 0.030 |
Why?
|
Arsenites | 1 | 2012 | 6 | 0.030 |
Why?
|
Hypertonic Solutions | 1 | 2012 | 17 | 0.030 |
Why?
|
Glutamate-tRNA Ligase | 1 | 2012 | 1 | 0.030 |
Why?
|
Virus Integration | 1 | 2012 | 16 | 0.030 |
Why?
|
Genes, Viral | 1 | 2012 | 116 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2012 | 44 | 0.030 |
Why?
|
Antibodies | 1 | 2014 | 350 | 0.030 |
Why?
|
DNA, Mitochondrial | 1 | 2013 | 183 | 0.030 |
Why?
|
Hybridomas | 1 | 2012 | 74 | 0.030 |
Why?
|
Luminescent Proteins | 1 | 2012 | 144 | 0.030 |
Why?
|
COS Cells | 1 | 2012 | 166 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2013 | 170 | 0.030 |
Why?
|
Nanostructures | 1 | 2013 | 77 | 0.030 |
Why?
|
Archaea | 1 | 2012 | 18 | 0.030 |
Why?
|
Eukaryota | 1 | 2012 | 44 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2017 | 2378 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 2012 | 139 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2012 | 262 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 772 | 0.020 |
Why?
|
AlkB Homolog 8, tRNA Methyltransferase | 1 | 2010 | 2 | 0.020 |
Why?
|
Fibroblasts | 1 | 2014 | 729 | 0.020 |
Why?
|
Hydroxylation | 1 | 2010 | 16 | 0.020 |
Why?
|
Environment | 1 | 2012 | 219 | 0.020 |
Why?
|
Bacillus | 1 | 2010 | 12 | 0.020 |
Why?
|
Recovery of Function | 1 | 2012 | 272 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 371 | 0.020 |
Why?
|
Molecular Conformation | 1 | 2010 | 96 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2017 | 3636 | 0.020 |
Why?
|
Odds Ratio | 1 | 2012 | 678 | 0.020 |
Why?
|
Protein Phosphatase 2 | 1 | 2010 | 15 | 0.020 |
Why?
|
RNA, Transfer, Asn | 1 | 2009 | 1 | 0.020 |
Why?
|
RNA, Transfer, Ile | 1 | 2009 | 1 | 0.020 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 27 | 0.020 |
Why?
|
Static Electricity | 1 | 2010 | 89 | 0.020 |
Why?
|
DNA Probes | 1 | 2009 | 77 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2014 | 599 | 0.020 |
Why?
|
Virus Assembly | 1 | 2009 | 21 | 0.020 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2010 | 83 | 0.020 |
Why?
|
Leucine | 1 | 2009 | 67 | 0.020 |
Why?
|
Adenosine Monophosphate | 1 | 2009 | 27 | 0.020 |
Why?
|
Survival Rate | 1 | 2013 | 1860 | 0.020 |
Why?
|
Immunoblotting | 1 | 2009 | 268 | 0.020 |
Why?
|
DNA Repair | 1 | 2010 | 356 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2012 | 1540 | 0.020 |
Why?
|
DNA Ligases | 1 | 2007 | 13 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2013 | 1208 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2007 | 63 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2007 | 220 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2007 | 692 | 0.020 |
Why?
|
Drug Resistance, Multiple | 1 | 2005 | 20 | 0.020 |
Why?
|
Neurons | 1 | 2014 | 1546 | 0.020 |
Why?
|
Escherichia coli K12 | 1 | 2005 | 4 | 0.020 |
Why?
|
Spliceosomes | 1 | 2005 | 45 | 0.020 |
Why?
|
Adolescent | 1 | 2017 | 8979 | 0.020 |
Why?
|
Ribonucleotides | 1 | 2004 | 13 | 0.020 |
Why?
|
Risk Assessment | 1 | 2012 | 2261 | 0.020 |
Why?
|
Intestine, Large | 1 | 2004 | 16 | 0.020 |
Why?
|
Rosaniline Dyes | 1 | 2004 | 9 | 0.020 |
Why?
|
Culture Techniques | 1 | 2004 | 91 | 0.020 |
Why?
|
Energy Transfer | 1 | 2004 | 25 | 0.020 |
Why?
|
Fluorescence | 1 | 2004 | 102 | 0.010 |
Why?
|
Esophagus | 1 | 2004 | 102 | 0.010 |
Why?
|
Stomach | 1 | 2004 | 108 | 0.010 |
Why?
|
Cell Cycle | 1 | 2005 | 502 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 2004 | 354 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2012 | 2207 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 3241 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2005 | 937 | 0.010 |
Why?
|
Intestine, Small | 1 | 2004 | 303 | 0.010 |
Why?
|
Risk Factors | 1 | 2012 | 5416 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2004 | 751 | 0.010 |
Why?
|
Models, Statistical | 1 | 2005 | 574 | 0.010 |
Why?
|
Enzyme Stability | 1 | 2001 | 39 | 0.010 |
Why?
|
Synchrotrons | 1 | 2000 | 28 | 0.010 |
Why?
|
Solutions | 1 | 2000 | 85 | 0.010 |
Why?
|
Genotype | 1 | 2005 | 1850 | 0.010 |
Why?
|
RNA, Protozoan | 1 | 1999 | 5 | 0.010 |
Why?
|
Middle Aged | 3 | 2004 | 25017 | 0.010 |
Why?
|
Adult | 3 | 2004 | 25640 | 0.010 |
Why?
|
Prospective Studies | 1 | 2007 | 4210 | 0.010 |
Why?
|
Aged | 2 | 2004 | 18402 | 0.010 |
Why?
|